Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Safflower has been used in traditional medicine for centuries and shows promise in treating heart, brain, and inflammatory conditions, but more research is needed to ensure its safety.

Lactococcus lactis strain H61 may reduce some ageing symptoms.

Stinging nettle has compounds that help with joint pain, arthritis, and prostate issues.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Hair follicles prevent NK cell attacks to avoid hair loss.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Stem Cell Educator therapy helps regrow hair and improve life quality in alopecia areata patients.

Abnormal ECM and immune cell interactions can cause skin diseases.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

MSC-derived exosomes may help in skin repair and regeneration.

Advanced imaging methods have improved understanding of cancer cell interactions and treatment strategies.

Adipose mesenchymal stem cells are best for skincare because they reduce inflammation and are safe and effective.

Different types of persistent hair loss after chemotherapy respond differently to treatments.